Trials | Outcomes | Follow-up periods | Types of participants |
---|---|---|---|
INFUSE AMI [11] | All-cause death, MACEs, definite and probable ST, HORIZONS major bleeding | 30Â days and 1Â year | STEMI undergoing PCI |
JUMBO TIMI 26 [12] | Non-CABG TIMI major and minor bleeding, minimal bleeding, MACEs, all-cause death, stroke, MI, recurrent ischemia, ST | 30Â days | Elective or urgent PCI |
PRASFIT ACS [13] | MACEs, all-cause death, CV death, ST, revascularization, MI, stroke, TIMI defined minor and major bleeding | 6Â months, 1Â year | ACS undergoing PCI |
PRINCIPLE TIMI 44 [14] | TIMI major and minor bleeding, overall bleeding events, ST, MI, MACEs | 1Â month | Elective PCI |
TAILOR [15] | MACEs, MI, stroke, ST, CV death | 1Â month, 1.5Â years | Elective PCI |
TRANSLATE ACS [16] | All-cause death, MI, stroke, revascularization, MACEs, BARC bleeding type 1–5, GUSTO moderate/severe bleeding | 6 months | ACS undergoing PCI |
TRIGGER PCI [17] | MACEs, CV death, MI, definite and probable ST, all-cause death, TIMI major bleeding | 8Â months | Elective PCI |
TRITON TIMI 38 [18] | MACEs, CV death, all-cause death, MI, stroke, revascularization, ST, TIMI major or minor bleeding | 15Â months | STEMI undergoing PCI |